Qualifying a Novel Clinical Trial Endpoint (iBOX) Predictive of Long-Term Kidney Transplant Outcomes

New immunosuppressive therapies that improve long-term graft survival are needed in kidney transplant. Critical Path Institute’s Transplant Therapeutics Consortium received a qualification opinion for the iBOX Scoring System as a novel secondary efficacy endpoint for kidney transplant clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Amanda, Loupy, Alexandre, Stegall, Mark, Helanterä, Ilkka, Kosinski, Luke, Frey, Eric, Aubert, Olivier, Divard, Gillian, Newell, Kenneth, Meier-Kriesche, Herwig-Ulf, Mannon, Roslyn, Dumortier, Thomas, Aggarwal, Varun, Podichetty, Jagdeep T., O’Doherty, Inish, Gaber, Ahmed Osama, Fitzsimmons, William E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Health Archive
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563802/
https://www.ncbi.nlm.nih.gov/pubmed/37822449
http://dx.doi.org/10.3389/ti.2023.11951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563802/
https://www.ncbi.nlm.nih.gov/pubmed/37822449
http://dx.doi.org/10.3389/ti.2023.11951

Ejemplares similares